Avancini, Alice
Trestini, Ilaria
Tregnago, Daniela
Belluomini, Lorenzo
Sposito, Marco
Insolda, Jessica
Schena, Federico
Milella, Michele
Pilotto, Sara
Funding for this research was provided by:
UniversitĂ degli Studi di Verona
Article History
Received: 10 June 2022
Accepted: 19 July 2022
First Online: 9 August 2022
Declarations
:
: The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. M.M. reports personal fees from Pfizer, EUSA Pharma and Astra Zeneca, outside the submitted manuscript. S.P. received honoraria or speakers’ fee from Astra-Zeneca, Eli-Lilly, BMS, Boehringer Ingelheim, MSD and Roche, outside the submitted manuscript. All remaining authors declare that they have no competing interests.